Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px

Deals > All

Total search results: 10123 | Ordered by Date (descending)
1 2 3 ... 100 101 102  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Oryzon Genomics–Citigroup: investor conference, 201812 supply service Oryzon attends Citi Global Healthcare Conference NY 2018-12-05
Argen-X–Piper Jaffray: investor conference, 201811 supply service Argenx presents at Piper Jaffray Healthcare Conference in NYC 2018-11-28
Argen-X–Evercore: investor conference, 201811 supply service Argenx Presents at Evercore ISI HealthCONx Conference 2018 2018-11-27
Erytech–Infopro Digital: investor conference, 201811 supply service Erytech at Actionaria 2018 in Paris 2018-11-22
Argen-X–Leucadia: investor conference, 201811 supply service Argenx presents at Jefferies 2018 London Healthcare Conference 2018-11-15
Argen-X–Credit Suisse: investor conference, 201811 supply service Argenx presents at Credit Suisse Annual Healthcare Conference 2018 2018-11-14
Erytech–Leucadia: investor conference, 201811 supply service Erytech at Jefferies London Healthcare Conference 2018 2018-11-14
Oryzon Genomics–Leucadia: investor conference, 201811 supply service Oryzon attends Jefferies London Healthcare Conference 2018 2018-11-14
Thermo Fisher–Leucadia: investor conference, 201811 supply service Thermo presents at Jefferies London Healthcare Conference 2018 2018-11-14
CRISPR Therapeutics–MaxCyte: gene transfer technology, 201811– license commercial to use Flow Electroporation techn for CRISPR-based I-O therapies 2018-11-09
Edinburgh Molecular Imaging–Optimum Strategic Communications: public relations, 201811 service existent by Optimum 2018-11-08
BioNTech–Univ Pennsylvania: mRNA technology, 201811– strategic research collab €na to develop mRNA vaccines for infectious disease 2018-11-05
Cristal Therapeutics–Instinctif Partners: public relations, 201811 service existent by Instinctif 2018-11-02
Curetis–SEVERAL: investment, 201811 private placement up to €18.4m with up to 7.4m new ordinary shares ANNOUNCED 2018-11-02
Omeicos–Forbion: investment, 201811 financing round Series C totalling €17m incl new + lead investor Forbion 2018-11-02
Omeicos–SEVERAL: investment, 201811 financing round Series C €17m led by new investor Forbion 2018-11-02
Pacific Biosciences–Illumina: investment, 201811– acquisition $1.2b of PaacBio by Illumina ANNOUNCED 2018-11-01
Sanofi–Denali Therapeutics: RIPK1 inhibitors, 201811– collab $125m upfront + >$1b + royalties RIPK1 inhibitors incl DNL 747 + DNL 758 2018-11-01
DefiniGen–MIT: CRISPR technology, 201810– commercial license to CRISPR-Cas9 gene editing technology from Broad Institute 2018-10-30
Grünenthal–AstraZeneca: esomeprazole, 201810– acquisition $922m of European rights to Nexium + ww ex US+JP rights to Vimovo 2018-10-30
Newron–EU (govt): credit, 201810– EIB/EFSI grant up to €40m to develop new CNS drugs 2018-10-30
Noscendo–SEVERAL: investment, 201810 financing round €7-digit led by Wieland Capital + incl HTGF + three business angels 2018-10-29
ProQR Therapeutics–Ionis Pharmaceuticals: RNA drugs, 2018110– license ww excl to IONIS-RHO-2.5Rx $2.5m upfront in shares + milestones + 20% royalties 2018-10-29
ProQR Therapeutics–LifeSci: public relations, 201810 service existent by LifeSci Public Relations 2018-10-29
Symphogen–Thermo Fisher: mass spectrometer, 201810 supply Q Exactive Plus Orbitrap LC-MS/MS with BioPharma Option for biopharma QC 2018-10-29
Themis Bioscience–SEVERAL: investment, 201810– IPO €35m to €55.3m on Euronext Amsterdam POSTPONED 11/18 2018-10-29
Thermo Fisher–Symphogen: mass spectrometry, 201810– collab developm biopharma QC workflows using Q Exactive Plus Orbitrap LC-MS/MS system 2018-10-29
Galecto Biotech–OrbiMed: investment, 201810 financing round Series C totalling $79m incl new + co-lead investor OrbiMed 2018-10-26
Galecto Biotech–SEVERAL: investment, 201810 financing round Series C €79m co-led by Ysios Capital + OrbiMed 2018-10-26
Galecto Biotech–Ysios Capital: investment, 201810 financing round Series C totalling $79m incl new + co-lead investor Ysios Capital 2018-10-26
Gamida Cell–SEVERAL: investment, 201810 IPO $50m+$7.5m with 6.25m+937.5k ordinary shares at $8/sahre at Nasdaq Global Market 2018-10-26
Oryzon Genomics–SEVERAL: investment, 201810 private placement €13m w 4.96m new common shares at €2.62/share 2018-10-26
Euformatics–EU (govt): grant, 201810– H2020 grant €700k for participation in GEMMA project 2018-10-25
Milestone Pharmaceuticals–Forbion: investment, 201810 financing round private totalling $80m incl existing + co-investor Forbion 2018-10-25
Milestone Pharmaceuticals–Novo Group: investment, 201810 financing round private totalling $80m incl existing + co-investor Novo Holdings A/S 2018-10-25
Milestone Pharmaceuticals–SEVERAL: investment, 201810 financing round private $80m led by RTW Investments 2018-10-25
BASF–MIT: CRISPR technology, 201810– license ww non-excl to CRISPR-Cpf1 technology from Broad Institute for agriculture + industrial microbiology 2018-10-24
Magnisense–SEVERAL: investment, 201810 financing round €5m from new + existing investors incl Meusinvest + Provestis + Concorde Capital + Minv 2018-10-24
Microbiotica–BPCE: investment, 201810 investment £4m by Seventure Partners’ Health for Life Capital Fund 2018-10-24
Microbiotica–Wellcome Trust: investment, 20810 exising investor Wellcome Sanger Institute 2018-10-24
Novartis–Philips: digital health, 201810– collab developm of SMART Suite by Alcon for cataract surgery on HealthSuite digital platform 2018-10-23
AstraZeneca–United Kingdom (govt): mass spectrometry, 201810– collab with Medicinces Discovery Catapult on acoustic mist ionisation mass spectrometry 2018-10-22
VTU–KonValue: investment, 201810 acquisition of VTU Technology by KonValue Group from VTU Holding GmbH + renaming as Validogen GmbH 2018-10-22
Amgen–Oxford Nanopore: DNA sequencing technology, 201810 supply existent deCODE Genetics uses Oxford Nanopore technology 2018-10-18
Endocyte–Novartis: investment, 201810– acquisition $2.1b in cash of Endocyte by Novartis ANNOUNCED 2018-10-18
Oxford Nanopore–Amgen: investment, 201810 investment £50m ($66m) acquisition of ordinary shares at same price as 3/18 fundraising 2018-10-18
Acticor Biotech–CapDecisif: investment, 201810 financing round Series B totalling €15.3m incl existing + co-investor CapDecisif Management (HK) 2018-10-17
Acticor Biotech–China Medical System: investment, 201810 financing round Series B totalling €15.3m incl new + co-investor CMS Medical Venture 2018-10-17
Acticor Biotech–Mirae Asset: investment, 201810 financing round Series B totalling €15.3m incl new + co-investor Mirae Asset Capital Co Ltd 2018-10-17
Acticor Biotech–NewCap: public relations, 201810 service existent by NewCap 2018-10-17
Acticor Biotech–Newton Biocapital: investment, 201810 financing round Series B totalling €15.3m incl new + lead investor Newton Biocapital 2018-10-17
Acticor Biotech–PERSON: investment, 201810 financing round Series B totalling €15.3m incl new + co-investor A&B (HK) 2018-10-17
Acticor Biotech–SEVERAL: investment, 201810 financing round Series B €15.3m led by new investor Newton Biocapital 2018-10-17
Oncgnostics–Thuringia (govt): investment, 201810 additional investment of €750k from bm|t + private investors 2018-10-17
Arcis:Altos–Zyme Communications: public relations, 201810 service existent by Zyme for Arcis Biotechnology 2018-10-16
Genedata–AstraZeneca: bioinformatics, 2018 collab existent development of Genedata Imagence s/w for HCS image analysis 2018-10-16
GSK–Warp Drive Bio: drug discovery, 201810 collab existent in oncology 2018-10-16
Immunicum–SEVERAL: investment, 201810– capital increase SEK351m with 40.3m new shares at SEK8.5/share 2018-10-16
JnJ–MeiraGTx: gene therapy, 201810– collab €na research + evaluation of riboswitch technology to regulate gene therapy constructs of JnJ Innovation 2018-10-16
Quantum Analytics–Bruker Corp: analytical instruments, 201810– distribution of S2 Puma + S2 Polar + D2 Phaser analysers in the US by Quantum Analytics 2018-10-16
Teleflex–Arcis:Altos: nucleic acid sample preparation technology, 201810– license to Teleflex from Arcis Biotechnology 2018-10-16
Warp Drive Bio–Revolution Medicines: investment, 201810 acquisition of Warp Drive Bio by Revolution Medicines 2018-10-16
LaVision BioTec–Miltenyi Biotec: investment, 201810 acquisition of LaVision BioTec GmbH by Miltenyi 2018-10-12
Gotham Therapeutics–Alexandria Real Estate: investment, 201810 financing round Series A totalling $54m incl co-investor Alexandria Venture Investments 2018-10-10
Gotham Therapeutics–Celgene: investment, 201810 financing round Series A totalling $54m incl co-investor Celgene Corp 2018-10-10
Gotham Therapeutics–Forbion: investment, 201810 financing round Series A totalling $54m incl $15m from co-lead investor Forbion IV Fund 2018-10-10
Gotham Therapeutics–GSK: investment, 201810 financing round Series A totalling $54m incl co-lead investor SR One 2018-10-10
Gotham Therapeutics–MacDougall Biomedical Communications: public relations, 201810 service existent by MacDougall 2018-10-10
Gotham Therapeutics–SEVERAL: investment, 201810 financing round Series A $54m co-led by Versant Ventures + Forbion + SR One 2018-10-10
Gotham Therapeutics–Versant Ventures: investment, 201810 financing round Series A totalling $54m incl founding + co-lead investor Versant Ventures 2018-10-10
SmartDyeLivery–PERSON: investment, 201810 financing round from bm|t + business angel from Munich 2018-10-10
SmartDyeLivery–SEVERAL: investment, 201810 financing round from bm|t + business angel from Munich 2018-10-10
SmartDyeLivery–Thuringia (govt): investment, 201810 financing round from bm|t + business angel from Munich 2018-10-10
Argen-X–Flanders (govt): grant, 201810 VLAIO grant €2.6m to explore new applications of ABDEG technology 2018-10-09
CRISPR Therapeutics–Chardan: investor conference, 201810 supply service CRISPR presents at Chardan Genetic Medicines Conference in New York 2018-10-09
Erytech–EZIL: investor conference, 201810 supply service Erytech at European Large & Midcap Event in Paris 2018-10-09
MeiraGTx–Chardan: investor conference, 201810 supply service MeiraGTx presents at Chardan Genetic Medicines Conference in New York 2018-10-09
MeiraGTx–W2O Group: public relations, 201810 service existent PR by W2O pure 2018-10-09
Rgenix–Novo Group: investment, 201810 financing round Series C totalling $40m incl existing + co-investor Novo Holdings AS 2018-10-09
Rgenix–SEVERAL: investment, 201810 financing round Series C $40m led by Lepu Medical + incl Novo Holdings + Sofinnova Partners et al 2018-10-09
Rgenix–Sofinnova: investment, 201810 financing round Series C totalling $40m incl existing + co-investor Sofinnova Partners 2018-10-09
DSM–Lipotype: mass spectrometry services, 201810 collab supply of shotgun skin lipidomics services by Lipotype to Royal DSM 2018-10-08
Lipoid–Lipotype: mass spectrometry services, 201810 collab supply of shotgun skin lipidomics services by Lipotype to Lipoid GmbH 2018-10-08
Sphingotec–HBM: investment, 201810 financing round totalling €20m incl co-lead investor HBM 2018-10-08
Sphingotec–SEVERAL: investment, 201810 financing round €20m co-led by HBM + Wellington Partners 2018-10-08
Sphingotec–Wellington Partners: investment, 201810 financing round totalling €20m incl co-lead investor Wellington Partners 2018-10-08
Vector Neurosciences–MeiraGTx: investment, 201810 acquisition in all-stock transaction by MeiraGTx 2018-10-05
Axcelead–ERS Genomics: CRISPR technology, 201810– license non-excl ww to CRISPR/Cas9 genome editing IP of ERS Genomics Ltd 2018-10-04
Clarus Ventures–Blackstone: investment, 201810– acqusition of Clarus by Blackstone to launch Blackstone Life Sciences investment platform 2018-10-04
GenAhead Bio–ERS Genomics: CRISPR technology, 201810– license non-excl to CRISPR/Cas9 genome editing IP of ERS Genomics Ltd 2018-10-04
Iqvia–United Kingdom (govt): clinical genomics, 201810– collab to develop integrated platform with clinical + genomics data with Genomics England 2018-10-04
Sanofi–Evotec: drug discovery, 201810– collab partnership BRIDGE LAB031 for early-stage projects out of academic research 2018-10-04
Arcis:Altos–SEVERAL: investment, 201810 financing round £1.25m of Arcis Biotechnology from existing + new investors 2018-10-02
Arcis:Altos–SEVERAL: investment, 201810– crowd funding round targeting £0.5m of Arcis Biotechnology via Capital Cell 2018-10-02
Curetis–Yorkville Group: credit, 201810– up to €20m convertible notes with attached warrants to YA II PN Ltd 2018-10-02
Oncgnositcs–Biotech Alliances International: business services, 201810– supply service support for global partnering + distribution strategy 2018-10-02
Roche–GO Therapeutics: antibody cancer drug, 201810– license ww excl $9m upfront/near-term +$186m milestones + royalties for bispecific antibody 2018-10-02
Sartorius–Genedata: bioinformatics, 201810 collab product integration of Genedata Bioprocess s/w with ambr mini bioreactos 2018-10-02
Akzo Nobel–Nouryon: investment, 201810c acquisition of Akzo Nobel Specialty Chemicals business by Carlyle Group + GIC renamed Nouryon 2018-10-01
B Braun–CeGaT: personalised medicine, 201810 collab establishment JV to develop personalised cancer vaccines CeCaVa GmbH & Co KG 2018-10-01
1 2 3 ... 100 101 102  next pagenext page



Advertisement

Picture [iito] – Putting Information into Context 600x102px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px

» top